Outcome measurement in clinical genetics services: a systematic review of validated measures.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Value in Health

• Publication date

  2008-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1524-4733.2007.00259.xPMID 18489673
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic health technology and economic evaluation

  2006cited by this paper
• An exploratory comparison of genetic counselling protocols for HNPCC predictive testing

  2005cited by this paper
• Development and validation of a Breast Cancer Genetic Counseling Knowledge Questionnaire.

  2005cited by this paper
• The decision evaluation scales.

  2005cited by this paper
• QUOTE‐geneca: development of a counselee‐centered instrument to measure needs and preferences in genetic counseling for hereditary cancer

  2005cited by this paper
• Design and psychometric evaluation of the Psychological Adaptation to Genetic Information Scale.

  2005cited by this paper
• Economic analyses of human genetics services: A systematic review

  2005cited by this paper
• Utilization of BRCA1/BRCA2 Mutation Testing in Newly Diagnosed Breast Cancer Patients

  2005cited by this paper
• Facilitating Informed Decision Making about Breast Cancer Risk and Genetic Counseling Among Women Calling the NCI's Cancer Information Service

  2005cited by this paper
• Screening and preventive behaviors one year after predictive genetic testing for hereditary nonpolyposis colorectal carcinoma

  2005cited by this paper
• Development of a knowledge scale about breast cancer and heredity (BCHK)

  2004cited by this paper
• Assessment of genetic testing and related counseling services: current research and future directions.

  2004influential reference
• Predictors of perceived breast cancer risk and the relation between perceived risk and breast cancer screening: a meta-analytic review.

  2004influential reference
• Measurement of psychological factors associated with genetic testing for hereditary breast, ovarian and colon cancers

  2004cited by this paper
• Outcome of five years of accelerated surveillance in patients at high risk for inherited breast/ovarian cancer: report of a phase II trial.

  2004cited by this paper
• Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients.

  2004cited by this paper
• Genomic deletions in MSH2 or MLH1 are a frequent cause of hereditary non‐polyposis colorectal cancer: Identification of novel and recurrent deletions by MLPA

  2003cited by this paper
• Incorporating the patient's perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001.

  2003cited by this paper
• Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study.

  2003cited by this paper
• Quality assessment of genetic markers used for therapy stratification.

  2003cited by this paper
• Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing.

  2003cited by this paper
• Parental decisions of prenatally detected sex chromosome abnormality.

  2002cited by this paper
• Effects of risk counseling on interest in breast cancer genetic testing for lower risk women

  2002cited by this paper
• Comprehensive Genetic Counseling for Families At Risk for HNPCC: Impact on Distress and Perceptions

  2002cited by this paper
• Suspected HNPCC and Amsterdam criteria II: evaluation of mutation detection rate, an international collaborative study

  2002cited by this paper
• Genetic Services

  2002cited by this paper
• What is the impact of genetic counselling in women at increased risk of developing hereditary breast cancer? A meta-analytic review.

  2002cited by this paper
• A national register for surveillance of inherited disorders: beta thalassaemia in the United Kingdom.

  2001cited by this paper
• Cancer‐specific worry interference in women attending a breast and ovarian cancer risk evaluation program: impact on emotional distress and health functioning

  2001cited by this paper
• Process studies in genetic counseling: peering into the black box.

  2001cited by this paper
• Parents' responses to disclosure of genetic test results of their children.

  2000cited by this paper
• Knowledge About Genetic Risk for Breast Cancer and Perceptions of Genetic Testing in a Sociodemographically Diverse Sample

  2000cited by this paper
• Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families.

  2000cited by this paper
• Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: findings from p53 and BRCA1 testing programs.

  2000cited by this paper
• Randomized trial of a specialist genetic assessment service for familial breast cancer.

  2000cited by this paper
• Goals, benefits, and outcomes of genetic counseling: client and genetic counselor assessment.

  2000cited by this paper
• Unpublished rating scales: A major source of bias in randomised controlled trials of treatments for schizophrenia

  2000cited by this paper
• Evaluation of a Shared Decision Making Program for Women Suspected to Have a Genetic Predisposition to Breast Cancer

  1999cited by this paper
• Development and Evaluation of a Decision Aid About Prenatal Testing for Women of Advanced Maternal Age

  1999cited by this paper
• Anxiety and adherence to breast self-examination in women with a family history of breast cancer.

  1999cited by this paper
• Women's knowledge, concerns and psychological reactions before undergoing an invasive procedure for prenatal karyotyping

  1999cited by this paper
• Psychological functioning before predictive testing for Huntington's disease: the role of the parental disease, risk perception, and subjective proximity of the disease

  1999cited by this paper
• The Genetic Knowledge Index: Developing a Standard Measure of Genetic Knowledge

  1999cited by this paper
• Utilisation of predictive, prenatal and diagnostic testing for Huntington's disease in Johannesburg.

  1999cited by this paper
• Psychosocial impact of genetic testing in familial medullary-thyroid carcinoma: a multicentric pilot-evaluation.

  1999cited by this paper
• Informed decision making: an annotated bibliography and systematic review.

  1999cited by this paper
• From what and why did genetics emerge as a medical specialism in the 1970s in the UK? A case-history of research, policy and services in the Manchester region of the NHS. National Health Service.

  1999cited by this paper
• Perceived personal control (PPC): a new concept in measuring outcome of genetic counseling.

  1999cited by this paper
• Perceived personal control (PPC): A new concept in measuring outcome of genetic counseling

  1999cited by this paper
• Consequences of the Delayed Diagnosis of Ataxia-Telangiectasia

  1998cited by this paper
• Patient decision making: An evaluation of two different methods of presenting information about a screening test

  1997cited by this paper
• Openness to Discuss Cancer in the Nuclear Family: Scale, Development, and Validation

  1997cited by this paper
• Information recall in genetic counselling: a pilot study of its assessment.

  1997cited by this paper
• Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument.

  1997cited by this paper
• Outcomes and process in genetic counselling

  1996cited by this paper
• BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.

  1996cited by this paper
• EVALUATING PATIENT'S KNOWLEDGE OF MATERNAL SERUM SCREENING

  1996cited by this paper
• Patient Satisfaction with Health Care Decisions

  1996cited by this paper
• Validation of client decision-making instruments in the context of psychiatry.

  1996cited by this paper
• Capturing Policy in Hearing-aid Decisions by Audiologists

  1995cited by this paper
• Validation of a Decisional Conflict Scale

  1995cited by this paper
• Predictive testing for Huntington's disease: risk perception, reasons for testing and psychological profile of test applicants.

  1995cited by this paper
• Diagnosis of acute intermittent porphyria in northern Sweden: an evaluation of mutation analysis and biochemical methods

  1995cited by this paper
• Mid-pregnancy genetic terminations of pregnancy--postnatal assessment and management.

  1995cited by this paper
• Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): a reevaluation of the Life Orientation Test.

  1994cited by this paper
• Subjective Quality of Life Assessment in Therapeutic Trials: Presentation of a New Instrument in France (SQLP: Subjective Quality of Life Profile) and First Results

  1994cited by this paper
• The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.

  1993cited by this paper
• Diagnosis of Duchenne and Becker muscular dystrophies by polymerase chain reaction. A multicenter study.

  1992cited by this paper
• Toward An Integrative Measure of Health and Well-Being

  1991cited by this paper
• Measurement precision and reliability in craniofacial anthropometry: implications and suggestions for clinical applications.

  1991cited by this paper
• Measurement precision and reliability in craniofacial anthropometry: implications and suggestions for clinical applications.

  1991cited by this paper
• Monitoring and blunting: validation of a questionnaire to assess styles of information seeking under threat.

  1987cited by this paper
• Medical Communication Behavior System: An Interactional Analysis System for Medical Interactions

  1986cited by this paper
• A classification of coping behavior based on multidimensional scaling of similarity ratings

  1979cited by this paper
• Development of instruments to measure counselees' knowledge of Down syndrome

  1978cited by this paper
• The medical interview satisfaction scale: Development of a scale to measure patient perceptions of physician behavior

  1978cited by this paper
• Genetic counseling.

  1975cited by this paper
• Personal control over aversive stimuli and its relationship to stress.

  1973cited by this paper
• Society and the adolescent self-image

  1966cited by this paper
• An ego-strength scale which predicts response to psychotherapy.

  1953cited by this paper

• A preliminary adaptation and validation of the genetic counseling outcome scale (GCOS‐24) for use in Greece

  2025cites this paper
• Assessing the prevalence of unmet need for genetic counseling in Canada and exploring associations with sociodemographic factors

  2025cites this paper
• A roadmap for genome projects to foster psychosocial and economic evidence to further policy and practice

  2025cites this paper
• De ning Core Outcomes of Reproductive Genetic Carrier Screening: A Delphi survey of Australian and New Zealand stakeholders

  2023cites this paper
• Cross‐cultural adaptation of the Genetic Counseling Outcome Scale (GCOS‐24) for use in Canada: A qualitative study

  2023cites this paper
• Defining core outcomes of reproductive genetic carrier screening: A Delphi survey of Australian and New Zealand stakeholders

  2023cites this paper
• Measuring quality and value in genetic counseling: The current landscape and future directions

  2022cites this paper
• Evaluating a communication aid for return of genetic results in families with hypertrophic cardiomyopathy: A randomized controlled trial

  2021cites this paper
• A new scale informed by the Reciprocal-Engagement Model for quality evaluation of genetic counselling by patients: Development and initial validation.

  2021cites this paper
• Systematic review of outcomes in studies of reproductive genetic carrier screening: Towards development of a core outcome set.

  2021cites this paper
• The Clinician-reported Genetic testing Utility InDEx (C-GUIDE): Preliminary evidence of validity and reliability.

  2021cites this paper
• Adaptation and preliminary validation of the genetic counseling outcome scale (GCOS-24) in a Brazilian genetic counseling setting.

  2020cites this paper
• Adaptation and preliminary validation of the genetic counseling outcome scale (GCOS-24) in a Brazilian genetic counselling setting ABSTRACT Health professionals working in services providing genetic counseling need objective instruments to assess genetic counseling outcomes

  2020cites this paper
• The Core Outcome DEvelopment for Carrier Screening (CODECS) study: protocol for development of a core outcome set

  2020cites this paper
• Proposed models for genetic counseling: Which quality indicators by Donabedian's model are more feasible?

  2020cites this paper
• Cancer genetic counseling for childhood cancer predisposition is associated with improved levels of knowledge and high satisfaction in parents

  2020cites this paper
• A Delphi study to prioritize genetic counseling outcomes: What matters most

  2020cites this paper
• Advancing the genetic counseling profession through research: Identification of priorities by the National Society of Genetic Counselors research task force

  2020cites this paper
• Exome sequencing compared with standard genetic tests for critically ill infants with suspected genetic conditions

  2020cites this paper
• Establishing the minimum clinically important difference for the Genetic Counseling Outcome Scale (GCOS‐24)

  2019cites this paper
• Assessing the Psychological Impact of Genetic Susceptibility Testing.

  2019cites this paper
• Health outcomes, utility and costs of returning incidental results from genomic sequencing in a Canadian cancer population: protocol for a mixed-methods randomised controlled trial

  2019cites this paper
• Evaluating empowerment in genetic counseling using patient‐reported outcomes

  2019cites this paper
• Cost-effectiveness analysis of reflex testing for Lynch syndrome in women with endometrial cancer in the UK setting

  2019cites this paper
• Proposal of a portuguese scale for quality assessment of genetic counselling by counselees

  2019influential citation
• Genetic Evaluation for Common, Chronic Disorders of Adulthood

  2019cites this paper
• A validated PROM in genetic counselling: the psychometric properties of the Dutch version of the Genetic Counselling Outcome Scale

  2019cites this paper
• Measuring the economic value of genetic counselling.

  2019cites this paper
• Developing a short-form of the Genetic Counselling Outcome Scale: The Genomics Outcome Scale.

  2019cites this paper
• Formulation of Genetic Counseling Format for Adult Bangladeshi Patients with Acute Myeloid Leukemia

  2018cites this paper
• Stakeholders’ views on the value of outcomes from clinical genetic and genomic interventions

  2018cites this paper
• How should costs and cost-effectiveness be considered in prenatal genetic testing?

  2018cites this paper
• Developing a genetic services assessment tool to inform quality improvement efforts in state genetic service delivery

  2018cites this paper
• Correction: Patient experience and utility of genetic information: a cross-sectional study among patients tested for cancer susceptibility and thrombophilia

  2018cites this paper
• Development of FOCUS-GC: Framework for Outcomes of Clinical Communication Services in Genetic Counseling

  2018cites this paper
• Translation and Cross-Cultural Adaptation with Preliminary Validation of GCOS-24 for Use in Spain

  2018cites this paper
• Patient experience and utility of genetic information: a cross-sectional study among patients tested for cancer susceptibility and thrombophilia

  2018cites this paper
• Patient-Centered Care in Breast Cancer Genetic Clinics

  2018cites this paper
• Patient outcomes of genetic counseling: Assessing the impact of different approaches to family history collection

  2018cites this paper
• [Proposal of a Portuguese Tool for Quality Assessment of Genetic Counselling: a New Tool for Healthcare Professionals].

  2018cites this paper
• Diagnosis of rare diseases under focus: impacts for Canadian patients

  2017cites this paper
• Translation and Adaptation of the Genetic Counselling Outcome Scale (GCOS-24) for Use in Denmark

  2017cites this paper
• Personal utility in genomic testing: a systematic literature review

  2017cites this paper
• Exploring the feasibility of delivering standardized genomic care using ophthalmology as an example

  2017cites this paper
• Outcomes of a Randomized Controlled Trial of Genomic Counseling for Patients Receiving Personalized and Actionable Complex Disease Reports

  2017cites this paper
• Exploring the Divide between Output and Outcome Measures in Health Care

  2017cites this paper
• Willingness to Pay for a Newborn Screening Test for Spinal Muscular Atrophy.

  2017cites this paper
• [Cultural scale adaptation and validation of the Spanish version of the BRCA Self-Concept Scale in women carriers at high risk for hereditary breast and ovarian cancer].

  2016cites this paper
• Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease: A Randomized Trial.

  2016cites this paper
• Defining Our Clinical Practice: The Identification of Genetic Counseling Outcomes Utilizing the Reciprocal Engagement Model

  2016cites this paper
• Clients’ Perception of Outcome of Team-Based Prenatal and Reproductive Genetic Counseling in Serbian Service Using the Perceived Personal Control (PPC) Questionnaire

  2016cites this paper
• Genomics and Patient Empowerment

  2016cites this paper
• [Cultural scale adaptation and validation of the Spanish version of the BRCA Self-Concept Scale in women carriers at high risk for hereditary breast and ovarian cancer].

  2016cites this paper
• Cost-effectiveness analysis of genomic tests: what are the methods challenges?

  2015cites this paper
• A randomized noninferiority trial of condensed protocols for genetic risk disclosure of Alzheimer's disease

  2015cites this paper
• Patient reported outcomes and patient empowerment in clinical genetics services

  2015influential citation
• Prevalence and detection of psychosocial problems in cancer genetic counseling

  2015cites this paper
• Genetics Health Professionals’ Views on Quality of Genetic Counseling Service Provision for Presymptomatic Testing in Late-Onset Neurological Diseases in Portugal: Core Components, Specific Challenges and the Need for Assessment Tools

  2015cites this paper
• Using needs-based frameworks for evaluating new technologies: an application to genetic tests.

  2015cites this paper
• Collating the knowledge base for core outcome set development: developing and appraising the search strategy for a systematic review

  2015cites this paper
• Featured Article A randomized noninferiority trial of condensed protocols for genetic risk disclosure of Alzheimer's disease

  2015cites this paper
• Specific Psychosocial Issues of Individuals Undergoing Genetic Counseling for Cancer – A Literature Review

  2014cites this paper
• Design and Implementation of a Randomized Controlled Trial of Genomic Counseling for Patients with Chronic Disease

  2014cites this paper
• Valuations of genetic test information for treatable conditions: the case of colorectal cancer screening.

  2014cites this paper
• Psychosocial Aspects of Hereditary Cancer (PAHC) questionnaire: development and testing of a screening questionnaire for use in clinical cancer genetics

  2014cites this paper
• The interactional dynamics of the genetic counselling session in a multicultural, antenatal setting

  2014cites this paper
• Psychosocial problems in cancer genetic counseling: detecting and facilitating communication

  2014cites this paper
• Identifying Outcomes of Clinical Genetic Services: Qualitative Evidence and Methodological Considerations

  2014influential citation
• Chapter 39 – Economic Issues and Genomic Medicine

  2013cites this paper
• Development and validation of the Psychological Adaptation Scale (PAS): use in six studies of adaptation to a health condition or risk.

  2013cites this paper
• Valuing the economic benefits of complex interventions: when maximising health is not sufficient.

  2013cites this paper
• What Counts as Effective Genetic Counselling for Presymptomatic Testing in Late-Onset Disorders? A Study of the Consultand’s Perspective

  2013cites this paper
• QUALITY INDICATORS TO ASSESS A COLORECTAL CANCER PREVENTION PROGRAM

  2013cites this paper
• Expectations and Outcomes of Genetics Services

  2013cites this paper
• Criteria for fairly allocating scarce health-care resources to genetic tests: which matter most?

  2013cites this paper
• Awareness of Genetic Counseling and Perceptions of its Purpose: A Survey of the Canadian Public

  2013cites this paper
• Non-invasive prenatal diagnosis for fetal sex determination: benefits and disadvantages from the service users’ perspective

  2012cites this paper
• Evaluation of a nurse-led haemophilia counselling service.

  2012cites this paper
• Quality Assessment of Genetic Counseling Process in the Context of Presymptomatic Testing for Late-Onset Disorders: A Thematic Analysis of Three Review Articles

  2012influential citation
• Factors associated with an individuals’ decision to withdraw from genetic counseling for BRCA1 and BRCA2 genes mutations: are personality traits involved?

  2011cites this paper
• [Cognitive, emotional and behavioral impact of an uncertain outcome after study of BRCA1/2: review of the literature].

  2011cites this paper
• Identifying the benefits and disbenefits of clinical genetics services : a framework for economic evaluation

  2011influential citation
• Scientific & recent submissions

  2011cites this paper
• Empowerment: qualitative underpinning of a new clinical genetics-specific patient-reported outcome

  2011cites this paper
• The Genetic Counseling Outcome Scale: a new patient‐reported outcome measure for clinical genetics services

  2011cites this paper
• Economic Issues and Genomic Medicine

  2010cites this paper
• Hypertrophic cardiomyopathy: towards an optimal strategy

  2010cites this paper
• Points to consider in assessing and appraising predictive genetic tests

  2010cites this paper
• Outcome Measures in Clinical Genetics Services

  2010cites this paper
• Misunderstandings Concerning Genetics Among Patients Confronting Genetic Disease

  2010cites this paper
• Disclosure of APOE genotype for risk of Alzheimer's disease.

  2009cites this paper
• Outcomes of genetics services: Creating an inclusive definition and outcomes menu for public health and clinical genetics services

  2009cites this paper
• Genetic counseling and cardiac care in predictively tested hypertrophic cardiomyopathy mutation carriers: The patients' perspective

  2009cites this paper
• Challenges of translating genetic tests into clinical and public health practice

  2009cites this paper
• Quality assurance in medical and public health genetics services: A systematic review

  2009influential citation
• Development, testing, and validation of a patient satisfaction questionnaire for use in the clinical genetics setting

  2009cites this paper
• APOE Genotype Disclosure for Risk of Alzheimer ’ s Disease : The REVEAL Study

  2009cites this paper
• Quality in clinical genetics

  2009cites this paper
• Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis.

  2008cites this paper
• What process attributes of clinical genetics services could maximise patient benefits?

  2008cites this paper